Abstract
If the addition of cytotoxic agents to methyilprednisolone pulse therapy improves survival and morbidity in systemic nephrites is controversial (1,2). Intermittent boluses of cyclophosphamide have been shown to reduce the adverse effects observed with daily chronic administration (3,4,5,6). To our knowledge, cyclophosphamide pulse therapy has never been tested on idiopathic glomerulonephropathy with or without nephrotic syndrome.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Cameron, J.S. In: 9th Int. Congress Nephrology (Eds R.R. Robinson), Springer-Verlag, Los Angeles 1984, pp. 1445–1463.
Bolton, W.K. In: 9th Int. Congress Nephrology (Eds. R.T.Robinson), Springer-Verlag, Los Angeles 1984, pp. 1464–1473.
Steinberg, A.D. N. Engl. J. Med. 310:458, 1984.
Dinant, H.J., Decker, J.L., Klippel, J.H., Balow, J.E., Plotz, P.H. and Steinberg, A.D. Ann. Intern. Med. 96:728, 1982.
Austin, H.A., Klippel, J.H., Balow, J.E., LeRiche, N.G., Steinberg, A.D., Plotz, P.H. and Decker, J.L. N. Engl. J. Med. 314:614–619, 1986.
Steinberg, A.D. Kidney Intern. 30:769–787, 1986.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Kluwer Academic Publishers
About this chapter
Cite this chapter
Grekas, D., Kalekou, H., Karkavelas, G., Settas, L., Alivanis, P., Pyrpasopoulos, M. (1989). Pulse Therapy with Cyclophosphamide in Primary and Sistemic Glomerulopathy Resistant to Steroid Treatment. In: Andreucci, V.E., Dal Canton, A. (eds) Current Therapy in Nephrology. Developments in Nephrology, vol 24. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0865-2_10
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0865-2_10
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8209-9
Online ISBN: 978-1-4613-0865-2
eBook Packages: Springer Book Archive